Reviva Pharmaceuticals Ownership 2024 | Who Owns Reviva Pharmaceuticals Now?

Overview ForecastFinancials Chart

Institutional Ownership

5.98%

Insider Ownership

14.94%

Retail Ownership

79.08%

Institutional Holders

12.00

Reviva Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WOODLINE PARTNERS LP	6.63%	0.02%	1,592,788	537,779	50.97%	2,038,769	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	5.17%	0.00%	1,241,493	386,896	45.27%	1,589,111	Jun 30, 2024
VANGUARD GROUP INC	4.27%	-	1,025,249	23,413	2.34%	1,312,319	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	4.22%	0.01%	1,013,791	187,191	22.65%	1,297,652	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	2.10%	0.09%	504,600	746	0.15%	645,888	Jun 30, 2024
SABBY MANAGEMENT, LLC	0.99%	0.20%	236,997	236,997	100.00%	303,356	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.98%	-	236,120	16,003	7.27%	302,294	Jun 30, 2024
COLONY GROUP, LLC	0.67%	0.00%	161,000	-10,000	-5.85%	206,000	Jun 30, 2024
POLAR ASSET MANAGEMENT PARTNERS INC.	0.64%	0.00%	154,800	-	-	198,144	Jun 30, 2024
UBS GROUP AG	0.55%	-	132,440	124,341	1535.26%	169,523	Jun 30, 2024
EMC CAPITAL MANAGEMENT	0.52%	0.08%	123,915	-	-	140,000	Jun 30, 2024
BLACKROCK INC.	0.43%	-	102,932	11,071	12.05%	131,753	Jun 30, 2024
STATE STREET CORP	0.30%	-	71,400	8,200	12.97%	91,392,000	Jun 30, 2024
NORTHERN TRUST CORP	0.24%	-	57,747	7,299	14.47%	73,916,000	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.13%	0.00%	31,068	31,068	100.00%	39,767	Jun 30, 2024
SOUND INCOME STRATEGIES, LLC	0.12%	0.00%	30,000	30,000	100.00%	38,400	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.12%	0.00%	29,392	29,392	100.00%	37,622,000	Jun 30, 2024
PALE FIRE CAPITAL SE	0.10%	0.00%	25,000	-	-	32,000	Jun 30, 2024
MORGAN STANLEY	0.07%	-	17,926	12,305	218.91%	22,946	Jun 30, 2024
	0.05%	0.01%	12,380	-	-	15,846	Jun 30, 2024

Reviva Pharmaceuticals's largest institutional shareholder is WOODLINE PARTNERS LP, holding 6.63% of the company's total share outstanding, currently valued at $2.04M. The top 10 institutional shareholders own together 26.21% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	0.99%	0.20%	236,997	236,997	100.00%	303,356	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	2.10%	0.09%	504,600	746	0.15%	645,888	Jun 30, 2024
EMC CAPITAL MANAGEMENT	0.52%	0.08%	123,915	-	-	140,000	Jun 30, 2024
WOODLINE PARTNERS LP	6.63%	0.02%	1,592,788	537,779	50.97%	2,038,769	Jun 30, 2024
	0.05%	0.01%	12,380	-	-	15,846	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	4.22%	0.01%	1,013,791	187,191	22.65%	1,297,652	Jun 30, 2024
POLAR ASSET MANAGEMENT PARTNERS INC.	0.64%	0.00%	154,800	-	-	198,144	Jun 30, 2024
PALE FIRE CAPITAL SE	0.10%	0.00%	25,000	-	-	32,000	Jun 30, 2024
SOUND INCOME STRATEGIES, LLC	0.12%	0.00%	30,000	30,000	100.00%	38,400	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	5.17%	0.00%	1,241,493	386,896	45.27%	1,589,111	Jun 30, 2024
COLONY GROUP, LLC	0.67%	0.00%	161,000	-10,000	-5.85%	206,000	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.00%	0.00%	1,000	1,000	100.00%	1,280	Jun 30, 2024
ARCHER INVESTMENT CORP	0.00%	0.00%	500	-	-	640	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.12%	0.00%	29,392	29,392	100.00%	37,622,000	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.13%	0.00%	31,068	31,068	100.00%	39,767	Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC	0.02%	0.00%	4,530	1,155	34.22%	5,798	Jun 30, 2024
UBS GROUP AG	0.55%	-	132,440	124,341	1535.26%	169,523	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.98%	-	236,120	16,003	7.27%	302,294	Jun 30, 2024
VANGUARD GROUP INC	4.27%	-	1,025,249	23,413	2.34%	1,312,319	Jun 30, 2024
NORTHERN TRUST CORP	0.24%	-	57,747	7,299	14.47%	73,916,000	Jun 30, 2024

The largest Reviva Pharmaceuticals shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 237.00K shares of Reviva Pharmaceuticals (RVPH), representing 0.20% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WOODLINE PARTNERS LP	6.63%	0.02%	1,592,788	537,779	50.97%	2,038,769	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	5.17%	0.00%	1,241,493	386,896	45.27%	1,589,111	Jun 30, 2024
SABBY MANAGEMENT, LLC	0.99%	0.20%	236,997	236,997	100.00%	303,356	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	4.22%	0.01%	1,013,791	187,191	22.65%	1,297,652	Jun 30, 2024
UBS GROUP AG	0.55%	-	132,440	124,341	1535.26%	169,523	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.13%	0.00%	31,068	31,068	100.00%	39,767	Jun 30, 2024
SOUND INCOME STRATEGIES, LLC	0.12%	0.00%	30,000	30,000	100.00%	38,400	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.12%	0.00%	29,392	29,392	100.00%	37,622,000	Jun 30, 2024
VANGUARD GROUP INC	4.27%	-	1,025,249	23,413	2.34%	1,312,319	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.98%	-	236,120	16,003	7.27%	302,294	Jun 30, 2024
MORGAN STANLEY	0.07%	-	17,926	12,305	218.91%	22,946	Jun 30, 2024
BLACKROCK INC.	0.43%	-	102,932	11,071	12.05%	131,753	Jun 30, 2024
STATE STREET CORP	0.30%	-	71,400	8,200	12.97%	91,392,000	Jun 30, 2024
NORTHERN TRUST CORP	0.24%	-	57,747	7,299	14.47%	73,916,000	Jun 30, 2024
SIMPLEX TRADING, LLC	0.01%	-	2,420	2,420	100.00%	3,000	Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC	0.02%	0.00%	4,530	1,155	34.22%	5,798	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.00%	0.00%	1,000	1,000	100.00%	1,280	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	2.10%	0.09%	504,600	746	0.15%	645,888	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	390	390	100.00%	499	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	125	125	100.00%	160	Jun 30, 2024

As of Jun 30 2024, Reviva Pharmaceuticals's largest institutional buyer is WOODLINE PARTNERS LP. The company purchased 537.78K stocks of RVPH, valued at $2.04M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-38,663	-100.00%	-	Jun 30, 2024
MARSHALL WACE, LLP	-	-	-	-34,868	-100.00%	-	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	50	-21,463	-99.77%	64	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.02%	-	3,945	-17,984	-82.01%	5,050	Jun 30, 2024
VONTOBEL HOLDING LTD.	-	-	-	-14,000	-100.00%	-	Jun 30, 2024
COLONY GROUP, LLC	0.67%	0.00%	161,000	-10,000	-5.85%	206,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-175	-100.00%	-	Jun 30, 2024
EMC CAPITAL MANAGEMENT	0.52%	0.08%	123,915	-	-	140,000	Jun 30, 2024
	0.05%	0.01%	12,380	-	-	15,846	Jun 30, 2024
POLAR ASSET MANAGEMENT PARTNERS INC.	0.64%	0.00%	154,800	-	-	198,144	Jun 30, 2024
PALE FIRE CAPITAL SE	0.10%	0.00%	25,000	-	-	32,000	Jun 30, 2024
ARCHER INVESTMENT CORP	0.00%	0.00%	500	-	-	640	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	125	125	100.00%	160	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	390	390	100.00%	499	Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC	2.10%	0.09%	504,600	746	0.15%	645,888	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.00%	0.00%	1,000	1,000	100.00%	1,280	Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC	0.02%	0.00%	4,530	1,155	34.22%	5,798	Jun 30, 2024
SIMPLEX TRADING, LLC	0.01%	-	2,420	2,420	100.00%	3,000	Jun 30, 2024
NORTHERN TRUST CORP	0.24%	-	57,747	7,299	14.47%	73,916,000	Jun 30, 2024
STATE STREET CORP	0.30%	-	71,400	8,200	12.97%	91,392,000	Jun 30, 2024

As of Jun 30 2024, Reviva Pharmaceuticals's biggest institutional seller is JPMORGAN CHASE & CO. The company sold -38.66K shares of RVPH, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	0.99%	0.20%	236,997	236,997	100.00%	303,356	Jun 30, 2024
SOUND INCOME STRATEGIES, LLC	0.12%	0.00%	30,000	30,000	100.00%	38,400	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.12%	0.00%	29,392	29,392	100.00%	37,622,000	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	0.00%	0.00%	1,000	1,000	100.00%	1,280	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	125	125	100.00%	160	Jun 30, 2024

Reviva Pharmaceuticals's largest new institutional shareholder by number of shares is SABBY MANAGEMENT, LLC, purchased 237.00K shares, valued at $303.36K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-38,663	-100.00%	-	Jun 30, 2024
MARSHALL WACE, LLP	-	-	-	-34,868	-100.00%	-	Jun 30, 2024
VONTOBEL HOLDING LTD.	-	-	-	-14,000	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-175	-100.00%	-	Jun 30, 2024

Reviva Pharmaceuticals's largest sold out institutional shareholder by shares sold is JPMORGAN CHASE & CO, sold -38.66K shares, valued at -, as of undefined.

Reviva Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.01%	5,640	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	979,715	-212,247	-17.81%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	175,364	11,669	7.13%	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	9,618	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	4,892	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,941	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,581	414	19.10%	Mar 31, 2024
iSHARES TRUST	0.00%	31,727	998	3.25%	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	461	215	87.40%	Mar 31, 2024

Reviva Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 5.64K shares, compromising 0.01% of its total assets.

Reviva Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	12	-62.50%
31 Mar, 24	32	-28.89%
31 Dec, 23	45	12.50%
30 Sep, 23	40	33.33%
30 Jun, 23	30	7.14%
31 Mar, 23	28	3.70%
31 Dec, 22	27	35.00%
30 Sep, 22	20	81.82%
30 Jun, 22	11	-35.29%
31 Mar, 22	17	54.55%
31 Dec, 21	11	-8.33%
30 Sep, 21	12	-
30 Jun, 21	12	71.43%
31 Mar, 21	7	133.33%
31 Dec, 20	3	-

As of 30 Jun 24, 12 institutions are holding Reviva Pharmaceuticals's shares, representing a decrease of -62.50% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	1,436,629	-74.18%
31 Mar, 24	5,563,459	5.85%
31 Dec, 23	5,255,878	97.34%
30 Sep, 23	2,663,385	1.20%
30 Jun, 23	2,631,706	91.30%
31 Mar, 23	1,375,662	5.53%
31 Dec, 22	1,303,532	41.58%
30 Sep, 22	920,693	-50.65%
30 Jun, 22	1,865,547	-1.93%
31 Mar, 22	1,902,181	-27.20%
31 Dec, 21	2,612,910	-0.31%
30 Sep, 21	2,621,081	-1.18%
30 Jun, 21	2,652,392	352.33%
31 Mar, 21	586,388	62.85%
31 Dec, 20	360,070	-

Reviva Pharmaceuticals (RVPH) has 1.44M shares outstanding as of 30 Jun 24, down -74.18% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	5.98%	1.12%
31 Mar, 24	23.15%	4.84%
31 Dec, 23	21.87%	15.52%
30 Sep, 23	11.87%	8.17%
30 Jun, 23	12.05%	30.36%
31 Mar, 23	6.30%	14.12%
31 Dec, 22	6.68%	29.26%
30 Sep, 22	4.78%	4.68%
30 Jun, 22	10.10%	9.52%
31 Mar, 22	10.30%	2.50%
31 Dec, 21	20.29%	10.06%
30 Sep, 21	14.20%	3.35%
30 Jun, 21	20.60%	51.06%
31 Mar, 21	6.35%	41.75%
31 Dec, 20	3.90%	-

As of 30 Jun 24, Reviva Pharmaceuticals is held by 5.98% institutional shareholders, representing a 1.12% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	8	-50.00%
31 Mar, 24	16	-40.74%
31 Dec, 23	27	42.11%
30 Sep, 23	19	-
30 Jun, 23	19	171.43%
31 Mar, 23	7	-65.00%
31 Dec, 22	20	122.22%
30 Sep, 22	9	50.00%
30 Jun, 22	6	-25.00%
31 Mar, 22	8	60.00%
31 Dec, 21	5	-16.67%
30 Sep, 21	6	-33.33%
30 Jun, 21	9	28.57%
31 Mar, 21	7	133.33%
31 Dec, 20	3	-

8 institutional shareholders have increased their position in RVPH stock as of 30 Jun 24 compared to 16 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	6	-14.29%
31 Dec, 23	7	-22.22%
30 Sep, 23	9	350.00%
30 Jun, 23	2	-80.00%
31 Mar, 23	10	233.33%
31 Dec, 22	3	-25.00%
30 Sep, 22	4	300.00%
30 Jun, 22	1	-66.67%
31 Mar, 22	3	-
31 Dec, 21	3	-
30 Sep, 21	3	200.00%
30 Jun, 21	1	-
31 Mar, 21	-	-
31 Dec, 20	-	-

- institutional shareholders have reduced their position in RVPH stock as of 30 Jun 24 compared to 6 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	12	-62.50%	1,436,629	-74.18%	5.98%	1.12%	8	-50.00%	-	-100.00%
31 Mar, 24	32	-28.89%	5,563,459	5.85%	23.15%	4.84%	16	-40.74%	6	-14.29%
31 Dec, 23	45	12.50%	5,255,878	97.34%	21.87%	15.52%	27	42.11%	7	-22.22%
30 Sep, 23	40	33.33%	2,663,385	1.20%	11.87%	8.17%	19	-	9	350.00%
30 Jun, 23	30	7.14%	2,631,706	91.30%	12.05%	30.36%	19	171.43%	2	-80.00%
31 Mar, 23	28	3.70%	1,375,662	5.53%	6.30%	14.12%	7	-65.00%	10	233.33%
31 Dec, 22	27	35.00%	1,303,532	41.58%	6.68%	29.26%	20	122.22%	3	-25.00%
30 Sep, 22	20	81.82%	920,693	-50.65%	4.78%	4.68%	9	50.00%	4	300.00%
30 Jun, 22	11	-35.29%	1,865,547	-1.93%	10.10%	9.52%	6	-25.00%	1	-66.67%
31 Mar, 22	17	54.55%	1,902,181	-27.20%	10.30%	2.50%	8	60.00%	3	-
31 Dec, 21	11	-8.33%	2,612,910	-0.31%	20.29%	10.06%	5	-16.67%	3	-
30 Sep, 21	12	-	2,621,081	-1.18%	14.20%	3.35%	6	-33.33%	3	200.00%
30 Jun, 21	12	71.43%	2,652,392	352.33%	20.60%	51.06%	9	28.57%	1	-
31 Mar, 21	7	133.33%	586,388	62.85%	6.35%	41.75%	7	133.33%	-	-
31 Dec, 20	3	-	360,070	-	3.90%	-	3	-	-	-

Reviva Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 21, 2022	Patel Purav	director	-	P-Purchase	Buy	3,000	$4.69	$14.07K	43,547
Oct 03, 2022	Narayan Prabhu	officer	Chief Financial Officer	P-Purchase	Buy	50,000	$1.66	$83.00K	100,000
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	869,565	$2.40	$2.09M	869,565
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	869,565	-	$86.96	869,565
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	513,834	$2.40	$1.23M	513,834
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	513,834	-	$51.38	513,834
Jun 30, 2022	Narayan Prabhu	officer	Chief Financial Officer	P-Purchase	Buy	50,000	$1.21	$60.67K	50,000

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 21, 2022	Patel Purav	director	-	P-Purchase	Buy	3,000	$4.69	$14.07K	43,547
Oct 03, 2022	Narayan Prabhu	officer	Chief Financial Officer	P-Purchase	Buy	50,000	$1.66	$83.00K	100,000
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	869,565	$2.40	$2.09M	869,565
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	869,565	-	$86.96	869,565
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	513,834	$2.40	$1.23M	513,834
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	513,834	-	$51.38	513,834
Jun 30, 2022	Narayan Prabhu	officer	Chief Financial Officer	P-Purchase	Buy	50,000	$1.21	$60.67K	50,000

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 22, 2023	SAXENA PARAG	director, 10 percent owner		J-Other	Buy	585,366	-	$58.54	585,366
Nov 22, 2023	SAXENA PARAG	director, 10 percent owner		J-Other	Buy	585,366	$5.00	$2.93M	585,366
Nov 14, 2023	Funtleyder Leslie D.	director	-	A-Award	Buy	8,200	$6.04	$49.53K	8,200
Nov 14, 2023	Patel Purav	director	-	A-Award	Buy	8,200	$6.04	$49.53K	8,200
Nov 14, 2023	SAXENA PARAG	director, 10 percent owner		A-Award	Buy	8,200	$6.04	$49.53K	8,200
Apr 27, 2023	Bhat Laxminarayan	director, 10 percent owner, officer	President and CEO	A-Award	Buy	443,000	$6.74	$2.99M	443,000
Apr 27, 2023	Bhat Laxminarayan	director, 10 percent owner, officer	President and CEO	A-Award	Buy	150,000	$6.74	$1.01M	150,000
Apr 27, 2023	Narayan Prabhu	officer	Chief Financial Officer	A-Award	Buy	170,000	$6.74	$1.15M	170,000
Nov 21, 2022	Patel Purav	director	-	P-Purchase	Buy	3,000	$4.69	$14.07K	43,547
Nov 14, 2022	SAXENA PARAG	director	-	A-Award	Buy	3,900	-	-	3,900
Nov 14, 2022	Patel Purav	director	-	A-Award	Buy	3,900	-	-	3,900
Nov 14, 2022	Margolin Richard A	director	-	A-Award	Buy	3,900	-	-	3,900
Nov 14, 2022	Funtleyder Leslie D.	director	-	A-Award	Buy	3,900	-	-	3,900
Oct 03, 2022	Narayan Prabhu	officer	Chief Financial Officer	P-Purchase	Buy	50,000	$1.66	$83.00K	100,000
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	869,565	$2.40	$2.09M	869,565
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	869,565	-	$86.96	869,565
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	513,834	$2.40	$1.23M	513,834
Sep 12, 2022	VEDANTA PARTNERS, LLC	10 percent owner	-	P-Purchase	Buy	513,834	-	$51.38	513,834
Jun 30, 2022	Narayan Prabhu	officer	Chief Financial Officer	P-Purchase	Buy	50,000	$1.21	$60.67K	50,000
Dec 10, 2021	SAXENA PARAG	director, 10 percent owner		A-Award	Buy	5,300	$3.78	$20.03K	5,300

The last insider buy of RVPH was made by Patel Purav on Nov 21 2022, buying 3,000 shares at $4.69 per share (worth $14.07K).

Reviva Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	4	-	-
Q2 2023	3	-	-
Q4 2022	5	-	-
Q3 2022	1	-	-
Q2 2022	1	-	-

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Reviva Pharmaceuticals's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	-	-
Q2 2023	-	-	-
Q4 2022	1	-	-
Q3 2022	1	-	-
Q2 2022	1	-	-

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Reviva Pharmaceuticals's stocks.

Reviva Pharmaceuticals Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
GRCL	Gracell Biotechnologies Inc.
CUE	Cue Biopharma, Inc.
EYPT	EyePoint Pharmaceuticals, Inc.
OCUP	Ocuphire Pharma, Inc.
FBIO	Fortress Biotech, Inc.
SGTX	Sigilon Therapeutics, Inc.
ACAD	ACADIA Pharmaceuticals Inc.
CABA	Cabaletta Bio, Inc.
ATHA	Athira Pharma, Inc.
SLS	SELLAS Life Sciences Group, Inc.
LTRN	Lantern Pharma Inc.
INAB	IN8bio, Inc.
UNCY	Unicycive Therapeutics, Inc.

RVPH Ownership FAQ

Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals is owned by institutional shareholders (5.98%), insiders (14.94%), and public (79.08%). The largest institutional shareholder of Reviva Pharmaceuticals is WOODLINE PARTNERS LP (6.63% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.01% of total shares).

Who are the major institutional shareholders of Reviva Pharmaceuticals?

Reviva Pharmaceuticals's major institutional shareholders are WOODLINE PARTNERS LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, SCHONFELD STRATEGIC ADVISORS LLC, and PARKMAN HEALTHCARE PARTNERS LLC. The top five shareholders own together 22.38% of the company's share outstanding.

How many Reviva Pharmaceuticals shareholders are there?

As of Jun 2024, there are 12 institutional shareholders of Reviva Pharmaceuticals.

What percentage of Reviva Pharmaceuticals is owned by WOODLINE PARTNERS LP?

WOODLINE PARTNERS LP owns 1.59M shares of Reviva Pharmaceuticals, representing 6.63% of the company's total shares outstanding, valued at $2.04M (as of Jun 2024).

What percentage of Reviva Pharmaceuticals is owned by MILLENNIUM MANAGEMENT LLC?

As of Jun 2024, MILLENNIUM MANAGEMENT LLC holds 1.24M shares of Reviva Pharmaceuticals (RVPH), compromising 5.17% of the company, valued at $1.59M.

What percentage of Reviva Pharmaceuticals is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC is the third largest holder of Reviva Pharmaceuticals. The company owns 1.03M of the company's shares outstanding (worth $1.31M).